Prophase Labs Inc reports results for the quarter ended in June - Earnings Summary

Prophase Labs

14/08/2024 14:32

* Prophase Labs Inc  PRPH.OQ  reported a quarterly adjusted
loss
of 33 cents​​ per share for the quarter ended in June, lower
than the same quarter last year, when the company reported EPS
of -20 cents.  The mean expectation of two analysts for the
quarter was for a loss of 24 cents per share. Wall Street
expected results to range from -41 cents to -8 cents per share.
    * Revenue fell 81.3% to $2.47 million from a year ago;
analysts
expected $11.18 million. 
    * Prophase Labs Inc's reported EPS for the quarter was a
loss
of 33 cents​.
    * Prophase Labs Inc shares had fallen by 40.9% this
quarter and
lost 45.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Prophase Labs Inc
is $18.50 
This summary was machine generated from LSEG data August 14 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.24          -0.33          Missed
 Mar. 31 2024      -0.28          -0.07          Beat
 Dec. 31 2023      -0.26          -0.51          Missed
 Sep. 30 2023      -0.19          -0.30          Missed